Willingness to accept herpes zoster vaccines and the influencing factors in China.

ABSTRACT:

Background

Herpes zoster increases the burden on the elderly in an aging society. Although an effective vaccine licensed by China Food and Drug Administration in 2019 was introduced into the market in June 2020, the willingness and influencing factors of herpes zoster vaccines in Chinese adults ≥ 50-years-old during coronavirus disease-2019 pandemic are yet to be elucidated.

Methods

An online questionnaire survey was conducted using a simple random sampling method in October 2021 for viewers of the broadcast program. A binary logistic regression and multiple response analysis were conducted for herpes zoster vaccine and vaccination willingness. Pareto's graphs were plotted to present the multiple-choice questions of influencing factors.

Results

A total of 3838 eligibl

SUBMITTER: Jiang B 

PROVIDER: S-EPMC9701420 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature